Jeremy Bender, CHIEF EXECUTIVE OFFICER at Day One Biopharmaceuticals, Inc. (DAWN), sold 15,230 shares at $15.25 ($232K) on 2024-02-16, disclosed to the SEC on 2024-02-20.
Open-market sale of $232k DAWN by CHIEF EXECUTIVE OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.25 | 7,615 | $116K | 50.0% |
| 2 | $15.25 | 7,615 | $116K | 50.0% |
| Total | $15.25 avg | 15,230 | $232K | 100% |
| Filing → |
| DAWN | SELL | 2025-08-19 | $217K | — | Filing → |
| DAWN | SELL | 2025-05-19 | $175K | — | Filing → |
| DAWN | SELL | 2025-02-21 | $288K | — | Filing → |